AN2 Therapeutics, Inc. ( ANTX) - Key Metrics
ANTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$0.16 | -$0.16 |
| 2026Q1 | $0 | -$0.29 | -$0.35 | -$0.35 |
| 2025Q4 | $0 | -$0.29 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.31 | -$0.21 | -$0.21 |
| 2025Q2 | $0 | -$0.21 | -$0.25 | -$0.25 |
ANTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.72 |
| 2026Q1 | 0% | -2.95 |
| 2025Q4 | 0% | -0.98 |
| 2025Q3 | 0% | -1.02 |
| 2025Q2 | 0% | -1.26 |
ANTX
Price: $5.99
52 week price:
Earnings Per Share: -1.05 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47599
Market Capitalization: 225.7 million